Efficacy of the PDCA cyclic care model in improving lung function and speed of recovery in children with mycoplasma pneumonia
Abstract
OBJECTIVE
To explore the effect of Plan-Do-Check-Act (PDCA) cycle nursing on the prognosis of children with mycoplasma pneumonia (MMP).
METHODS
Clinical data of 112 children with MMP who were admitted to Hangzhou Ninth People's Hospital from September 2020 to December 2022 were retrospectively analyzed. The children were divided into a control group (56 cases, receiving routine care) and a PDCA group (56 cases, receiving PDCA care) according to nursing interventions. Blood gas analysis, pulmonary function, inflammation levels, clinical treatment, complications, and satisfaction were compared between the two group pre- and post-care.
RESULTS
The results showed that the children in PDCA group experienced a more significant improvement in blood oxygen levels, evidenced by increased PaO2 and SaO2 levels and decreased PaCO2 levels, as well as enhanced lung function. Meanwhile, PDCA care was more effective in reducing interleukin-6, C-reactive protein, and tumor necrosis factor-alpha levels in children. In addition, children in the PDCA group recovered more quickly, with shorter times to temperature normalization, cough improvement, asthma resolution, lung rales disappearance, and hospital stay. Moreover, PDCA nursing effectively reduced the incidence of intrapulmonary and extrapulmonary complications, and improved care quality and patient satisfaction.
CONCLUSIONS
The PDCA cycle nursing model significantly improves the prognosis of children with MMP by promoting faster recovery,…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.